The FDA granted 20 spine device clearances in July.
The Latest
A new study published in the Journal of Neurosurgery: Spine examines key trends in spinal epidural hematomas.
Doug Widener, MD, joined Atlanta-based Resurgens Orthopaedics.
Surgeons, payers, administrators and investors across the country have come to recognize the SwiftPath Program for its work in outpatient joint replacement.
CoreLink launched Scaltoff Wire, a stackable guide wire for its Entasis Sacroiliac Joint Fusion System.
Emerging Implant Technologies acquired a portfolio of patents from Morgan P. Lorio, MD, of Nashville, Tenn.-based Hughston Clinic Orthopaedics.
Researchers compared preoperative and postoperative function and pain following total joint replacement in obese patients, according to a study published by The Journal of Bone & Joint Surgery.
The U.S. knee implant is anticipated to continue growing through 2024, according to a Market Research Reports analysis.
The spinal cord stimulator is set to grow through 2027, according to a Market Research Reports Search Engine analysis.
Cutting Edge Spine named Luke Maher its new director of U.S. sales.